191 related articles for article (PubMed ID: 25501511)
1. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
[TBL] [Abstract][Full Text] [Related]
2. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
[TBL] [Abstract][Full Text] [Related]
3. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
Ghoshal A; Ghosh SS
Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
[TBL] [Abstract][Full Text] [Related]
4. Secreted Frizzled related protein-4 (sFRP4) promotes epidermal differentiation and apoptosis.
Maganga R; Giles N; Adcroft K; Unni A; Keeney D; Wood F; Fear M; Dharmarajan A
Biochem Biophys Res Commun; 2008 Dec; 377(2):606-611. PubMed ID: 18938133
[TBL] [Abstract][Full Text] [Related]
5. Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours.
Drake J; Shearwood AM; White J; Friis R; Zeps N; Charles A; Dharmarajan A
Eur J Gynaecol Oncol; 2009; 30(2):133-41. PubMed ID: 19480240
[TBL] [Abstract][Full Text] [Related]
6. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
Carmon KS; Loose DS
Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells.
Perumal V; Pohl S; Keane KN; Arfuso F; Newsholme P; Fox S; Dharmarajan A
Exp Cell Res; 2016 Feb; 341(2):218-24. PubMed ID: 26868304
[TBL] [Abstract][Full Text] [Related]
8. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
9. The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain.
Perumal V; Dharmarajan AM; Fox SA
Int J Oncol; 2017 Jul; 51(1):362-368. PubMed ID: 28534940
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein 4 and its implication in obesity and type-2 diabetes.
Bukhari SA; Yasmin A; Zahoor MA; Mustafa G; Sarfraz I; Rasul A
IUBMB Life; 2019 Nov; 71(11):1701-1710. PubMed ID: 31301214
[TBL] [Abstract][Full Text] [Related]
11. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
12. Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a.
Perumal V; Krishnan K; Gratton E; Dharmarajan AM; Fox SA
Int J Biochem Cell Biol; 2015 Jul; 64():91-6. PubMed ID: 25805505
[TBL] [Abstract][Full Text] [Related]
13. sFRP4 signalling of apoptosis and angiostasis uses nitric oxide-cGMP-permeability axis of endothelium.
Saran U; Mani KP; Balaguru UM; Swaminathan A; Nagarajan S; Dharmarajan AM; Chatterjee S
Nitric Oxide; 2017 Jun; 66():30-42. PubMed ID: 28267592
[TBL] [Abstract][Full Text] [Related]
14. Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients.
Jacob F; Ukegjini K; Nixdorf S; Ford CE; Olivier J; Caduff R; Scurry JP; Guertler R; Hornung D; Mueller R; Fink DA; Hacker NF; Heinzelmann-Schwarz VA
PLoS One; 2012; 7(2):e31885. PubMed ID: 22363760
[TBL] [Abstract][Full Text] [Related]
15. Placental expression of secreted frizzled related protein-4 in the rat and the impact of glucocorticoid-induced fetal and placental growth restriction.
Hewitt DP; Mark PJ; Dharmarajan AM; Waddell BJ
Biol Reprod; 2006 Jul; 75(1):75-81. PubMed ID: 16540541
[TBL] [Abstract][Full Text] [Related]
16. MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats.
Miao CG; Huang C; Huang Y; Yang YY; He X; Zhang L; Lv XW; Jin Y; Li J
Cell Signal; 2013 Mar; 25(3):598-608. PubMed ID: 23200852
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis.
Cho HY; Choi HJ; Sun HJ; Yang JY; An JH; Cho SW; Kim SW; Kim SY; Kim JE; Shin CS
Bone; 2010 Aug; 47(2):263-71. PubMed ID: 20472109
[TBL] [Abstract][Full Text] [Related]
18. Secreted frizzled related protein 4 (sFRP4) update: A brief review.
Pawar NM; Rao P
Cell Signal; 2018 May; 45():63-70. PubMed ID: 29360572
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-152 modulates the canonical Wnt pathway activation by targeting DNA methyltransferase 1 in arthritic rat model.
Miao CG; Yang YY; He X; Huang C; Huang Y; Qin D; Du CL; Li J
Biochimie; 2014 Nov; 106():149-56. PubMed ID: 25194984
[TBL] [Abstract][Full Text] [Related]
20. Finding Novel Anti-carcinomas Compounds by Targeting SFRP4 Through Molecular Modeling, Docking and Dynamic Simulation Studies.
Hassan M; Azhar M; Abbas Q; Raza H; Moustafa AA; Shahzadi S; Ashraf Z; Seo SY
Curr Comput Aided Drug Des; 2018; 14(2):160-173. PubMed ID: 29332600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
